BioCentury
ARTICLE | Management Tracks

Borio adds public health, biodefense chops to Arch

FDA, In-Q-Tel alum will focus on manufacturing, clinical trials, novel therapies

July 23, 2021 10:50 PM UTC

As a venture partner at Arch, Luciana Borio will be advising Arch on and helping develop new investment opportunities related to manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs, Borio told BioCentury.

She will also advise Arch portfolio companies, including National Resilience Inc., which is applying advanced manufacturing technologies to make biopharmaceutical supply chains more secure. ...